0001209191-19-008591.txt : 20190208
0001209191-19-008591.hdr.sgml : 20190208
20190208165110
ACCESSION NUMBER: 0001209191-19-008591
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190206
FILED AS OF DATE: 20190208
DATE AS OF CHANGE: 20190208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lavelle Erin
CENTRAL INDEX KEY: 0001737613
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36431
FILM NUMBER: 19580642
MAIL ADDRESS:
STREET 1: C/O ALDER BIOPHARMACEUTICALS, INC.
STREET 2: 11804 NORTH CREEK PARKWAY SOUTH
CITY: BOTHELL
STATE: WA
ZIP: 98011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALDER BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001423824
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11804 NORTH CREEK PARKWAY SOUTH
CITY: BOTHELL
STATE: WA
ZIP: 98011
BUSINESS PHONE: 425-205-2900
MAIL ADDRESS:
STREET 1: 11804 NORTH CREEK PARKWAY SOUTH
CITY: BOTHELL
STATE: WA
ZIP: 98011
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-06
0
0001423824
ALDER BIOPHARMACEUTICALS INC
ALDR
0001737613
Lavelle Erin
11804 NORTH CREEK PARKWAY SOUTH
BOTHELL
WA
98011
0
1
0
0
Chief Operating Officer
Stock Option (Right to Buy)
14.00
2019-02-06
4
A
0
150000
0.00
A
2029-02-05
Common Stock
150000
150000
D
The shares subject to this option shall vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of January 1, 2019 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter, for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
/s/ Julia Stark, Attorney-in-Fact
2019-02-08